Trial NCT03856112

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-00994
Secondary IDs: 10248 NCI-2019-00994 UM1CA186644

Last trial update was posted on 2019-03-26

MeSH Interventions

BB 1101 Dexamethasone Dexamethasone acetate Glycine Ichthammol Ixazomib Venetoclax

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma t(11;14) Negative

Stopping Reasons

Per CTEP, Martha Khrum this study is withdrawn. Changing status to update CT.gov

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID